NeuroSense Therapeutics Ltd. Proceeds From Issue Of Ordinary Shares
NeuroSense Therapeutics Ltd. (NRSN) reported Proceeds From Issue Of Ordinary Shares of $306.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2024-04-04.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfOrdinaryShares · last filed 2024-04-04
| Period end | Proceeds From Issue Of Ordinary Shares 6 month | Proceeds From Issue Of Ordinary Shares 12 month |
|---|---|---|
| 2022-12-31 | $306.00K 20-F · filed 2024-04-04 | |
| 2022-06-30 | $306.00K 6-K · filed 2023-08-16 |